CFM
AKRO

Capricorn Fund Managers’s Akero Therapeutics AKRO Stock Holding History

Capricorn Fund Managers’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-149,200
Closed -$7.08M – 85
2025
Q3 		$7.08M Buy
+149,200
New +$7.22M 2.38% 14

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Capricorn Fund Managers's AKRO Position: Q4 2025 in Review

Capricorn Fund Managers sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 149,200 shares — an estimated $7.08M sold.

Capricorn Fund Managers first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $7.08M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Capricorn Fund Managers reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Capricorn Fund Managers sold 149,200 Akero Therapeutics shares in Q4 2025, an estimated $7.08M.
  • Capricorn Fund Managers first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
  • Capricorn Fund Managers's Akero Therapeutics position peaked at $7.08M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Capricorn Fund Managers's 13F filing for Q4 2025, filed 21 Jan 2026.